🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Join us at the EASL #LiverCancerSummit 2025, on 20-22 February in Paris & online! 🌍 🦀Dive into cutting-edge research, expert-led sessions, and networking with global specialists in liver cancer care. Don’t miss this chance to explore breakthroughs in hepatocellular and

➡️El 25 y 26 de noviembre tuvo lugar el curso BCLC UPDATE: Forging a multidisciplinary ecosystem to revolutionize liver cancer management, dirigido por la Dra. María Reig Más de 170 médicos de todo el mundo asistieron para informarse de las novedades en #CáncerdeHígado

🌟 Neutralizing GDF-15: A global milestone in overcoming anti-PD-1/PD-L1 resistance tumors. Proud to contribute to opens new possibilities for refractory #HCC patients #CatalYm Hospital Clínic CIBERehd IDIBAPS 🔗 pubmed.ncbi.nlm.nih.gov/39663448/

Entering the new era in IO for HCC. Happy and proud to see Maria Reig Marta Fortuny and Marco Sanduzzi Zamparelli leading the HCC subcohort from the BCLC GROUP

💥 What a week for the @BCLC_Group! Alejandro Forner leading the Asociación Española para el Estudio del Hígado meeting 🔬 Marta Fortuny Marco Sanduzzi Zamparelli Maria Reig co-authoring a breakthrough study: PMID: 39663448 🚀 #RETO project celebrating its 1st year with Asociación Española Contra el Cáncer & Immune4ALL 💪✨ #TeamScience

🚨 Ending the year with a major update! 🚨 New @EASL Guidelines for #HCC 2024 📑 #EASL reaffirms the BCLC GROUP strategy as the prognostic classification and highlights multidisciplinary, patient-centered care as pillars of healthcare quality. journal-of-hepatology.eu/article/S0168-…

Pattern of progression in different cancer types emerges as a key predictor for post-progression OS. We first described it in hepatocellular carcinoma in doi.org/10.1002/hep.26… and commented in extense its value in pubmed.ncbi.nlm.nih.gov/31371809/. Fully validated now.

🔬Nos reunimos con el equipo de la Dra. María Reig Maria Reig del Hospital Clínic-IDIBAPS para conocer los últimos avances del proyecto RETO. Avances en el Tratamiento del Cáncer de Hígado: Modificar el Microbioma como Nueva Estrategia para Potenciar la Inmunoterapia, dotado con

Maria Reig presents the BCLC approach to the management of HCC patients at intermediate stage at ASCO GI. Expert dissection to guide clinical decision in a very challenging scenario. Hospital Clínic IDIBAPS CIBERehd Asociación Española Contra el Cáncer

SCDigestologia #SCD2025 30è Curs de Formació en Digestologia. Immunoteràpia a les malalties digestives: indicacions i maneig dels efectes adversos. Noves malalties i nous reptes. Ponents d’alt nivell.

☢️ Investigadors del #CLÍNIC - @IDIBAPS analitzen el potencial de la #IA per a la classificació de lesions hepàtiques en informes de ressonància magnètica ✅ L'eina podria millorar l'eficiència en la classificació i reduir la càrrega de treball Info 👉clinicbarcelona.org/ca/noticies/an…

And finally a group picture with current members (physicians and nurses) and current and past fellows. A happy group with cohessive philosophy is a blessing and provides results for clinical care. No success without human touch!!@hospitalclinic IDIBAPS CIBERehd Asociación Española Contra el Cáncer

Marco Sanduzzi Zamparelli presenting at the 2025 annette herr meeting the study about the role of microbiota in the response to IOs in HCC and the impact of proton pump inhibitors. Collaborative translational research at its best Hospital Clínic IDIBAPS CIBERehd Asociación Española Contra el Cáncer Microbiologia H.Clínic Barcelona

Gracias por apoyar la investigación y generar sinergias!! el proyecto #RETO lo represantamos junto con Josepmaria Argemi Hospital Clínic IDIBAPS Cima Universidad de Navarra Maria Varela Climent Casals-Pascual Marco Sanduzzi Zamparelli CIBERehd gemma iserte Marta Fortuny

🇪🇺 Noves guies europees per millorar el tractament del carcinoma hepatocel·lular. 🧑‍⚕️ Especialistes del #CLÍNIC-IDIBAPS i la Clínica Universidad de Navarra han liderat l'elaboració d'aquestes guies de l'EASLnews. ➕ info 👉 f.mtr.cool/ngtltahywa

Cardiovascular events in patients with HCC treated with IOs: pubmed.ncbi.nlm.nih.gov/40245453/ A nice multicenter study coordinated from our group by Marta Fortuny & Maria Reig joined by Maria Varela from @HUCA. Hospital Clínic IDIBAPS CIBERehd Asociación Española Contra el Cáncer

Session about the challenges around systemic therapy just finished EASLnews Our very own Marco Sanduzzi Zamparelli exposed his BCLC thinking about how to navigate treatment sequencing. Clinical expertise is an important asset Hospital Clínic IDIBAPS CIBERehd Asociación Española Contra el Cáncer

nllarch and gemma iserte were active at the EASLnews session about PROMS and PREMS because of her expertise as Advance Practice Nurses. Key members of tge team Hospital Clínic IDIBAPS CIBERehd Asociación Española Contra el Cáncer

Thanks Grainne!!

👏🏻👏🏻👏🏻 Far to be a individual achievement, this is an award for all the BCLC GROUP with an obvious special thanks to my mentors and directors Maria Reig and Jordi Bruix 🥳 Some pictures to prove it